Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies
Abstract The urgent need for a treatment of COVID-19 has left researchers with limited choice of either developing an effective vaccine or identifying approved/investigational drugs developed for other medical conditions for potential repurposing, thus bypassing long clinical trials. In this work, w...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/91d1b92f687040aebb2d043b3dfc7e60 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|